The measurement of serum CA-125 antigen is a standard procedure in the management of patients with advanced ovarian cancer. A study by Markman et al. showed that decreased concentration of serum ...

The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood ...

Quite a few tumor ... plasma and CA 72-4 seem to perform at least equally. However, the combination of both tumor markers might provide a further benefit in gastric cancer. Neither marker should ...